CH204078A - Process for the preparation of a serum-coupled antimony compound of tartranilic acid. - Google Patents

Process for the preparation of a serum-coupled antimony compound of tartranilic acid.

Info

Publication number
CH204078A
CH204078A CH204078DA CH204078A CH 204078 A CH204078 A CH 204078A CH 204078D A CH204078D A CH 204078DA CH 204078 A CH204078 A CH 204078A
Authority
CH
Switzerland
Prior art keywords
serum
coupled
antimony compound
antimony
acid
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellsc Farbenindustrie
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Publication of CH204078A publication Critical patent/CH204078A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/90Antimony compounds
    • C07F9/902Compounds without antimony-carbon linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Description

  

  Verfahren zur Herstellung einer an Serum gekuppelten     Antimonverbindung     der     Tartranilsäure.       Man hat     bereits        Azoproteine    hergestellt,  jedoch sind Verbindungen von     Azoproteinen     mit     Antimon        bisher    nicht bekannt gewesen.

    Es wurde nun :gefunden, dass man     diese    neu  artigen     Verbindungen    erhalten kann, wenn  man     Antimonverbindungen    aromatischer  Amine     diazotiert    und an Eiweiss kuppelt  oder wenn man das     Antimon    nachträglich  in     ein        Azoprotein    einführt.  



  Das vorliegende     Patent    betrifft ein Ver  fahren zur Herstellung einer an Serum ge  kuppelten     Antimonverbindung    der     Tartranil-          säure,    welches dadurch     gekennzeichnet    ist,

    dass man die durch     Einwirkung    von     Anti-          montrioxyd    auf     Tartranilsäure    im alka  lischen Medium erhältliche     Antimonverbin-          dung    der     Tartranilsäjure        diazotiert    und die       Dia.zoverbindun.g    mit     Serum        kuppelt.     



  Die so erhältliche     alkalimetallfreie        Anti-          monverbindung    ist eine rotgefärbte Substanz  mit Eiweisscharakter,     die    in     Wasser    löslich,    in Säuren     und        organischen        Lösungsmitteln     unlöslich ist; sie soll für chemotherapeutische  Zwecke     verwendet    werden,.

      <I>Beispiel:</I>  0,3 g     Tartramilsäure    werden     in        Wasser     gelöst, mit     Natronlauge        neutralisiert        und    mit  0,3 g     Antimon-trioxyd    eine     Zeitlang    gekocht.

    Die     überstehende        Lösung    wird nun von un  gelöstem     Antimontriogyd        abfiltriert,        mit     Salzsäure angesäuert und unter     Eiskühlung     mit     Natriumnitritlösung        diazotiert.    25     cm3          Pferdeserum    wenden .mit 10     cm@    2     n-Natrium-          carbonatlösung    versetzt und die     Diazonium-          lösung    dazu gegeben.

   Nach 3     Stunden        wird     das     Azoprotein    mit Säure     gefällt,    in ver  dünnter Natronlauge auf-genommen und  gegen     destilliertes    Wasser dialysiert. Die  nach     beendeter    Dialyse auf 60     em@        ein-          geengte        Lösung    hat eine     Konzentration    von       2,5%    und enthält     0,0127o        Antimon.  



  Process for the preparation of a serum-coupled antimony compound of tartranilic acid. Azo proteins have already been made, but compounds of azo proteins with antimony have not yet been known.

    It has now been found that these new compounds can be obtained if antimony compounds of aromatic amines are diazotized and coupled to protein or if the antimony is subsequently introduced into an azo protein.



  The present patent relates to a process for the production of an antimony compound of tartranilic acid coupled to serum, which is characterized in

    that the antimony compound of tartranilic acid obtained by the action of antimony trioxide on tartranilic acid in an alkaline medium is diazotized and the diazo compound is coupled with serum.



  The alkali metal-free antimony compound that can be obtained in this way is a red-colored substance with a protein character that is soluble in water, but insoluble in acids and organic solvents; it is intended to be used for chemotherapeutic purposes.

      <I> Example: </I> 0.3 g of tartramilic acid are dissolved in water, neutralized with sodium hydroxide solution and boiled for a while with 0.3 g of antimony trioxide.

    The supernatant solution is then filtered off from undissolved antimony triogide, acidified with hydrochloric acid and diazotized with sodium nitrite solution while cooling with ice. Turn 25 cm3 of horse serum, add 10 cm @ 2 N sodium carbonate solution and add the diazonium solution.

   After 3 hours the azo protein is precipitated with acid, taken up in dilute sodium hydroxide solution and dialyzed against distilled water. The solution, which is reduced to 60 em @ after the end of dialysis, has a concentration of 2.5% and contains 0.0127o antimony.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung einer au Serum gekuppelten Antimonverbindung der Tartranilsäure, dadurch gekennzeichnet, PATENT CLAIM: Process for the production of an antimony compound of tartranilic acid coupled to serum, characterized in that dass man die durch die Einwirkung von Antimon- trioxyd auf Tartranilsäure in alkalischem Medium erhältliche alkalimeta.llfreie Anti- monverbindung der Taxtranilsäure diazotiert und die Diazoverbindung mit Serum kuppelt. that the alkali metal-free antimony compound of taxtranilic acid, which is obtained by the action of antimony trioxide on tartranilic acid in an alkaline medium, is diazotized and the diazo compound is coupled with serum. Die so erhältliche Antimonverbindung ist eine rot gefärbte Substanz mit Eiweiss- t5 die in Wasser löslich, in Säuren und organischen Lösungsmitteln unlöslich ist; sie soll für chemotherapeutische Zweck verwendet werden. The antimony compound that can be obtained in this way is a red colored substance with protein which is soluble in water but insoluble in acids and organic solvents; it is intended to be used for chemotherapeutic purpose.
CH204078D 1936-08-13 1936-08-13 Process for the preparation of a serum-coupled antimony compound of tartranilic acid. CH204078A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH204078T 1936-08-13

Publications (1)

Publication Number Publication Date
CH204078A true CH204078A (en) 1939-04-15

Family

ID=4443982

Family Applications (1)

Application Number Title Priority Date Filing Date
CH204078D CH204078A (en) 1936-08-13 1936-08-13 Process for the preparation of a serum-coupled antimony compound of tartranilic acid.

Country Status (1)

Country Link
CH (1) CH204078A (en)

Similar Documents

Publication Publication Date Title
CH204078A (en) Process for the preparation of a serum-coupled antimony compound of tartranilic acid.
DE673536C (en) Process for the preparation of compounds of azoproteins with antimony
CH178407A (en) Process for the preparation of a disazo dye.
CH185055A (en) Process for the production of a new azo dye.
CH106418A (en) Process for the production of a new azo dye.
CH211020A (en) Process for the production of a new azo dye.
CH148005A (en) Process for the preparation of a disazo dye.
CH204379A (en) Process for the production of the azo protein from mercury dianiline and serum protein.
CH195465A (en) Process for the preparation of the silver compound of serum protein azo-2-mercapto-benzoic acid.
CH210601A (en) Process for the preparation of a substantive trisazo dye.
CH212118A (en) Process for the production of a new dye.
CH165408A (en) Process for the production of a new azo dye.
CH148003A (en) Process for the preparation of a disazo dye.
CH229358A (en) Process for the preparation of a trisazo dye.
CH185054A (en) Process for the production of a new azo dye.
CH106413A (en) Process for the production of a new azo dye.
CH253877A (en) Process for the production of a new azo dye.
CH186169A (en) Process for the production of a new azo dye.
CH203603A (en) Process for the production of a new azo dye.
CH213003A (en) Process for the preparation of a substantive trisazo dye.
CH90845A (en) Process for the preparation of a diazotization dye.
CH155674A (en) Process for the production of a new azo dye.
CH191423A (en) Process for the preparation of a monoazo dye.
CH191424A (en) Process for the preparation of a monoazo dye.
CH204443A (en) Process for the production of a new azo dye.